<DOC>
	<DOC>NCT02347943</DOC>
	<brief_summary>This study evaluates long-term safety and effectiveness of primary sinus surgery in a real-world population of adults with chronic rhinosinusitis (CRS) or recurrent acute rhinosinusitis (RARS). This post-market study will evaluate sinus surgery performed using commercially available sinus instrumentation (e.g. sinus balloon catheters, powered microdebriders, manual instruments).</brief_summary>
	<brief_title>Global Sinus Surgery Registry</brief_title>
	<detailed_description />
	<mesh_term>Sinusitis</mesh_term>
	<criteria>Age â‰¥ 18 years or minimum adult age as required by local regulations The subject has a planned primary sinus surgery, which includes either traditional transnasal endoscopic sinus surgery (ESS), balloon sinus dilation (BSD) or a hybrid procedure Subjects diagnosed by ENT surgeon with chronic rhinosinusitis (CRS) or recurrent acute rhinosinusitis (RARS) per AAOHNS or EPOS adult sinusitis clinical practice guidelines The subject has been informed of the nature of the registry and has consented to participate and authorized the collection and release of medical information by signing a consent form Subject is able to read and understand local language Prior sinus surgery. Septoplasty, Nasal Polypectomy, Septorhinoplasty, Nasal Valve and Turbinate Reduction surgeries are not exclusions Planned surgery of any of the following : orbital decompression, skull base, neoplasm, lacrimal, UPPP, aesthetic surgery, Potts Puffy tumor, Draf III Planned external approaches (i.e. not transnasal) Planned offlabel usage of balloon sinus dilation products. Balloon sinus dilation performed with a nonAcclarent balloon product</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2015</verification_date>
</DOC>